March 2017 - Volume 72 - Issue 3

  • Aaron B. Caughey
    Mary E. Norton
    Lee A. Learman
  • 0029-7828
  • 1533-9866
  • 12 issues / year
  • Obstetrics & Gynecology 44/80
  • 1.718
Published
Other Supplements
Current Issue Highlights

Fetal Diagnosis and Therapy

International Standards for Symphysis-Fundal Height Based on Serial Measurements From the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: Prospective Cohort Study...

Papageorghiou, Aris T.; Ohuma, Eric O.; Gravett, Michael G.; More

Obstetrical & Gynecological Survey . 72(3):141-143, March 2017.

Newborn Medicine

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Fowler, Mary G.; Qin, Min; Fiscus, Susan A.; More

Obstetrical & Gynecological Survey . 72(3):143-145, March 2017.

Ethics, Medicolegal Issues, and Public Policy

Medical Complications of Pregnancy

Obstetrical Complications

Vaginal Progesterone as Maintenance Treatment After an Episode of Preterm Labour (PROMISE) Study: A Multicentre, Double-blind, Randomised, Placebo-Controlled Trial

Palacio, Montse; Cobo, Teresa; Antolín, Eugenia; More

Obstetrical & Gynecological Survey . 72(3):151-153, March 2017.

Genetics

Sensitivity of Fetal RhD Screening for Safe Guidance of Targeted Anti–D Immunoglobulin Prophylaxis: Prospective Cohort Study of a Nationwide Programme in the Netherlands

de Haas, Masja; Thurik, Florentine F.; van der Ploeg, Catharina P. B.; More

Obstetrical & Gynecological Survey . 72(3):155-157, March 2017.


Operative Gynecology

Urogynecology

Is Mirabegron Equally as Effective When Used as First- or Second-Line Therapy in Women With Overactive Bladder?

Serati, Maurizio; Roberti Maggiore, Umberto Leone; Sorice, Paola; More

Obstetrical & Gynecological Survey . 72(3):160-161, March 2017.

Office Gynecology

Gynecologic Oncology

Infertility/Reproductive Technologies

Menopause